BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28534264)

  • 1. Adherence to an elemental diet for preventing postoperative recurrence of Crohn's disease.
    Ohara N; Mizushima T; Iijima H; Takahashi H; Hiyama S; Haraguchi N; Inoue T; Nishimura J; Shinzaki S; Hata T; Matsuda C; Yamamoto H; Doki Y; Mori M
    Surg Today; 2017 Dec; 47(12):1519-1525. PubMed ID: 28534264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elemental diet therapy plays a significant role in preventing surgical recurrence of Crohn's disease in the era of biologics.
    Shinozaki M; Yokoyama T; Saigusa N; Sato H; Yazawa K; Tsurita G; Kurokawa T; Hata K; Yokoyama Y
    Surg Today; 2021 Feb; 51(2):250-257. PubMed ID: 32812075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of nutritional therapy for perforating and non-perforating Crohn's disease.
    Ikeuchi H; Yamamura T; Nakano H; Kosaka T; Shimoyama T; Fukuda Y
    Hepatogastroenterology; 2004; 51(58):1050-2. PubMed ID: 15239244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of elemental diet (ED) on surgical treatment in Crohn's disease.
    Ikeuchi H; Kusunoki M; Yanagi H; Yamamura T; Fukuda Y; Shimoyama T
    Hepatogastroenterology; 2000; 47(32):390-2. PubMed ID: 10791197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct retrospective comparison of adalimumab and infliximab in preventing early postoperative endoscopic recurrence after ileocaecal resection for crohn's disease: results from the MULTIPER database.
    Kotze PG; Yamamoto T; Danese S; Suzuki Y; Teixeira FV; de Albuquerque IC; Saad-Hossne R; de Barcelos IF; da Silva RN; da Silva Kotze LM; Olandoski M; Sacchi M; Yamada A; Takeuchi K; Spinelli A
    J Crohns Colitis; 2015 Jul; 9(7):541-7. PubMed ID: 25820017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-operative recurrence of Crohn's disease: A prospective study at 5 years.
    Onali S; Calabrese E; Petruzziello C; Lolli E; Ascolani M; Ruffa A; Sica G; Rossi A; Chiaramonte C; Pallone F; Biancone L
    Dig Liver Dis; 2016 May; 48(5):489-494. PubMed ID: 26905749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
    Lobatón T; López-García A; Rodríguez-Moranta F; Ruiz A; Rodríguez L; Guardiola J
    J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn's Disease.
    Fortinsky KJ; Kevans D; Qiang J; Xu W; Bellolio F; Steinhart H; Milgrom R; Greenberg G; Cohen Z; Macrae H; Stempak J; McLeod R; Silverberg MS
    Dig Dis Sci; 2017 Jan; 62(1):188-196. PubMed ID: 27778204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of concomitant elemental diet therapy in scheduled infliximab therapy in patients with Crohn's disease to prevent loss of response.
    Kamata N; Oshitani N; Watanabe K; Watanabe K; Hosomi S; Noguchi A; Yukawa T; Yamagami H; Shiba M; Tanigawa T; Watanabe T; Tominaga K; Fujiwara Y; Arakawa T
    Dig Dis Sci; 2015 May; 60(5):1382-8. PubMed ID: 25532505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myenteric plexitis is a risk factor for endoscopic and clinical postoperative recurrence after ileocolonic resection in Crohn's disease.
    Decousus S; Boucher AL; Joubert J; Pereira B; Dubois A; Goutorbe F; Déchelotte PJ; Bommelaer G; Buisson A
    Dig Liver Dis; 2016 Jul; 48(7):753-8. PubMed ID: 27005857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease Recurrence.
    Ferrante M; Papamichael K; Duricova D; D'Haens G; Vermeire S; Archavlis E; Rutgeerts P; Bortlik M; Mantzaris G; Van Assche G;
    J Crohns Colitis; 2015 Aug; 9(8):617-24. PubMed ID: 25926532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopy-based management decreases the risk of postoperative recurrences in Crohn's disease.
    Boucher AL; Pereira B; Decousus S; Goutte M; Goutorbe F; Dubois A; Gagniere J; Borderon C; Joubert J; Pezet D; Dapoigny M; Déchelotte PJ; Bommelaer G; Buisson A
    World J Gastroenterol; 2016 Jun; 22(21):5068-78. PubMed ID: 27275099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study.
    Armuzzi A; Felice C; Papa A; Marzo M; Pugliese D; Andrisani G; Federico F; De Vitis I; Rapaccini GL; Guidi L
    J Crohns Colitis; 2013 Dec; 7(12):e623-9. PubMed ID: 23810678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of postoperative recurrence of Crohn's disease: Tripterygium wilfordii polyglycoside versus mesalazine.
    Ren J; Wu X; Liao N; Wang G; Fan C; Liu S; Ren H; Zhao Y; Li J
    J Int Med Res; 2013 Feb; 41(1):176-87. PubMed ID: 23569144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of endoscopic monitoring in postoperative Crohn's disease patients already receiving pharmacological prevention of recurrence.
    González-Lama Y; Blázquez I; Suárez CJ; Oliva B; Matallana V; Calvo M; Vera I; Abreu L
    Rev Esp Enferm Dig; 2015 Oct; 107(10):586-90. PubMed ID: 26437976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life of patients and medical cost of "half elemental diet" as maintenance therapy for Crohn's disease: secondary outcomes of a randomised controlled trial.
    Takagi S; Utsunomiya K; Kuriyama S; Yokoyama H; Takahashi S; Umemura K; Iwabuchi M; Takahashi H; Takahashi S; Kinouchi Y; Hiwatashi N; Funayama Y; Sasaki I; Tsuji I; Shimosegawa T
    Dig Liver Dis; 2009 Jun; 41(6):390-4. PubMed ID: 18945653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
    Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB
    Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn's Disease Patients Classified i2 on the Rutgeerts Score.
    Bayart P; Duveau N; Nachury M; Zerbib P; Gerard R; Branche J; Maunoury V; Wils P; Boruchowicz A; Boualit M; Laberenne JE; Manolache O; Desreumaux P; de Chambrun GP; Pariente B
    Dig Dis Sci; 2016 Oct; 61(10):2986-2992. PubMed ID: 27401274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of an elemental diet for patients with crohn's disease and its association with amino acid metabolism.
    Nakano M; Tominaga K; Hoshino A; Sugaya T; Kanke K; Hiraishi H
    Saudi J Gastroenterol; 2017; 23(1):20-27. PubMed ID: 28139496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative therapy with infliximab prevents long-term Crohn's disease recurrence.
    Regueiro M; Kip KE; Baidoo L; Swoger JM; Schraut W
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1494-502.e1. PubMed ID: 24440221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.